SLAM
NVAX icon

Swiss Life Asset Management’s Novavax NVAX Stock Holding History

Swiss Life Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,513
Closed -$331K – 659
2022
Q1 		$331K Buy
+4,513
New +$402K ﹤0.01% 545
2021
Q3 		– Sell
-15,951
Closed -$5.55M – 567
2021
Q2 		$5.55M Buy
+15,951
New +$2.92M 0.06% 308

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Swiss Life Asset Management's NVAX Position: Q2 2022 in Review

Swiss Life Asset Management sold out of Novavax (NVAX) in Q2 2022, closing a stake of 4,513 shares — an estimated $331K sold.

Swiss Life Asset Management first reported a position in NVAX in Q2 2021 and held it in 2 quarters. The position peaked at $5.55M in Q2 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • Swiss Life Asset Management reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • Swiss Life Asset Management sold 4,513 Novavax shares in Q2 2022, an estimated $331K.
  • Swiss Life Asset Management first reported a position in Novavax in Q2 2021 and held it in 2 quarters.
  • Swiss Life Asset Management's Novavax position peaked at $5.55M in Q2 2021.
  • 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on Swiss Life Asset Management's 13F filing for Q2 2022, filed 9 Dec 2025.